ARA-290: Can It Repair Small Nerve Fibers?

ARA-290: Can It Repair Small Nerve Fibers?

ARA-290, also called cibinetide, is an investigational 11-amino-acid peptide designed from erythropoietin biology to activate tissue-protective signaling without stimulating red-blood-cell production.

In this episode, John Garrett, RN, breaks down the innate repair receptor, why ARA-290 has been studied in small-fiber neuropathy, what randomized human trials in sarcoidosis and type 2 diabetes actually found, and why objective nerve-fiber signals are interesting—but not the same thing as an approved therapy.

You'll learn:

• What ARA-290/cibinetide is

• How it differs from full-length erythropoietin

• What the innate repair receptor is

• Why researchers studied corneal nerve fibers

• What the 22-patient pilot trial showed

• What the 64-patient phase 2b trial showed

• Why pain and nerve-fiber endpoints did not tell exactly the same story

• What is known—and not known—about safety

• Why online ARA-290 products should not be assumed equivalent to trial material

Explore the Peptides Explained app: app.peptidesexplained.info

Learn more through Peptide Solutions: peptide-solutions.info

Educational content only. ARA-290 is investigational and is not an FDA-approved treatment for neuropathy or any other clinical indication.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(66)

The Secretome Explained: Could Cellular Signaling Transform Medicine?

The Secretome Explained: Could Cellular Signaling Transform Medicine?

True-Sciences.com use code Pep20 for 20% off your first order What if some of the most important discoveries in regenerative medicine come not from replacing damaged cells, but from understanding how ...

11 Nov 16min

Monkeys Got Shredded On Peptides?!!

Monkeys Got Shredded On Peptides?!!

Weight loss is not the same thing as fat loss. A 2025 monkey study combining semaglutide with experimental myostatin and activin A antibodies raised the possibility of protecting lean mass while losin...

9 Nov 12min

Where Do Peptides Fit in Pain and Recovery? | Dr. Hany Demian

Where Do Peptides Fit in Pain and Recovery? | Dr. Hany Demian

True-Sciences.com use code Pep20 for 20% off your first order Dr. Hany Demian joins John Garrett for a conversation about chronic pain, injury recovery, regenerative medicine, and where peptides may f...

4 Nov 1h 5min

BPC-157 Update: HHS Policy, Human Evidence & WADA Status

BPC-157 Update: HHS Policy, Human Evidence & WADA Status

BPC-157 is back in the compounding-policy conversation—but what does HHS's new notice actually change, and what does the human evidence show? In this revisit, John Garrett looks at BPC-157's proposed ...

2 Nov 19min

Beyond Stem Cells: Secretomes, Cellular Repair & Longevity | Sanjiv Lal

Beyond Stem Cells: Secretomes, Cellular Repair & Longevity | Sanjiv Lal

What if the future of regenerative medicine isn't just about stem cells—but the biological messages those cells send? In this episode of Peptides Explained, John Garrett sits down with Sanjiv Lal, fou...

28 Okt 1h

CJC-1295 Deep Dive: What the Human Evidence Actually Shows

CJC-1295 Deep Dive: What the Human Evidence Actually Shows

True-Sciences.com Use Code Pep20 for 20% off. A careful look at CJC-1295: the growth-hormone pathway, the distinction between DAC and no-DAC naming, what small human studies measured, the terminated P...

26 Okt 14min

The Silent Killer in Your Kitchen? Seed Oils, Inflammation & What to Cook With Instead with Cherie Calbom

The Silent Killer in Your Kitchen? Seed Oils, Inflammation & What to Cook With Instead with Cherie Calbom

Seed oils may be hiding in more of your everyday foods than you realize. In this episode of Peptides Explained, host John talks with Cherie Calbom, MS—known as the Juice Lady—about seed oils, cooking ...

21 Okt 44min

Retatrutide: Is It Time to Panic? Lilly's Lawsuits, the Science, and What Happens Next

Retatrutide: Is It Time to Panic? Lilly's Lawsuits, the Science, and What Happens Next

Eli Lilly is taking legal action against businesses selling products labeled retatrutide. What do the lawsuits actually establish—and what don't they? John Garrett separates pending legal allegations ...

19 Okt 13min

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
psykodrama
hvordan-har-du-det-mann
fryktlos
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
foreldreradet
rss-ekteskapet
morten-ramm-lar-kakla-ga-til-du-sovner
klimaks
rss-kunsten-a-leve
hjernesterk
g-punktet
rss-kull
treningsprat
rss-loping-for-nybegynnere
rss-dagen-for-dagen